目次

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive landscape

2 Market Overview
2.1. Market definition
2.2. Market analysis

3 Market Data
3.1. Market value
3.2. Market volume

4 Market Segmentation
4.1. Geography segmentation

5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast

6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry

7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of the leading player?
7.3. Have there been any recent developments in the market?

8 Company Profiles
8.1. Teva Pharmaceutical Industries Limited
8.2. Viatris Inc.
8.3. Pfizer Inc.
8.4. Novartis AG

9 Macroeconomic Indicators
9.1. Country data

10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine

List of Tables
Table 1: United Kingdom generics market value: $ million, 2017-22
Table 2: United Kingdom generics market volume: %, 2017-22
Table 3: United Kingdom generics market geography segmentation: $ million, 2022
Table 4: United Kingdom generics market value forecast: $ million, 2022-27
Table 5: United Kingdom generics market volume forecast: %, 2022-27
Table 6: Teva Pharmaceutical Industries Limited: key facts
Table 7: Teva Pharmaceutical Industries Limited: Annual Financial Ratios
Table 8: Teva Pharmaceutical Industries Limited: Key Employees
Table 9: Viatris Inc.: key facts
Table 10: Viatris Inc.: Annual Financial Ratios
Table 11: Viatris Inc.: Key Employees
Table 12: Viatris Inc.: Key Employees Continued
Table 13: Pfizer Inc.: key facts
Table 14: Pfizer Inc.: Annual Financial Ratios
Table 15: Pfizer Inc.: Key Employees
Table 16: Pfizer Inc.: Key Employees Continued
Table 17: Novartis AG: key facts
Table 18: Novartis AG: Annual Financial Ratios
Table 19: Novartis AG: Key Employees
Table 20: Novartis AG: Key Employees Continued
Table 21: United Kingdom size of population (million), 2018-22
Table 22: United Kingdom gdp (constant 2005 prices, $ billion), 2018-22
Table 23: United Kingdom gdp (current prices, $ billion), 2018-22
Table 24: United Kingdom inflation, 2018-22
Table 25: United Kingdom consumer price index (absolute), 2018-22
Table 26: United Kingdom exchange rate, 2018-22

List of Figures
Figure 1: United Kingdom generics market value: $ million, 2017-22
Figure 2: United Kingdom generics market volume: %, 2017-22
Figure 3: United Kingdom generics market geography segmentation: % share, by value, 2022
Figure 4: United Kingdom generics market value forecast: $ million, 2022-27
Figure 5: United Kingdom generics market volume forecast: %, 2022-27
Figure 6: Forces driving competition in the generics market in the United Kingdom, 2022
Figure 7: Drivers of buyer power in the generics market in the United Kingdom, 2022
Figure 8: Drivers of supplier power in the generics market in the United Kingdom, 2022
Figure 9: Factors influencing the likelihood of new entrants in the generics market in the United Kingdom, 2022
Figure 10: Factors influencing the threat of substitutes in the generics market in the United Kingdom, 2022
Figure 11: Drivers of degree of rivalry in the generics market in the United Kingdom, 2022